Santorlin (Generic Name: Triptorelin Acetate) is a peptide medication in the form of a lyophilized powder for injection, designed for sustained release. Each vial contains a specific amount of Triptorelin Acetate which, after reconstitution with the appropriate solvent, is administered via intramuscular injection. This drug is engineered to release the active substance gradually, maintaining a steady and controlled level in the body to provide the desired therapeutic effect. Santorlin acts on the hypothalamic-pituitary-gonadal axis, inhibiting the secretion of sex hormones and subsequently reducing testosterone or estrogen levels. This makes the drug highly effective for treating hormone-dependent conditions such as prostate cancer and hormonal disorders. Its precise, long-term performance reduces the frequency of injections and improves patient compliance. This product is manufactured by specialist teams at the Biosun Pharmed knowledge-based group, utilizing modern peptide production technologies and rigorous quality control processes in compliance with international cGMP standards.
Santorlin is a potent Gonadotropin-Releasing Hormone (GnRH) agonist. Initially, it causes a short-term increase in LH and FSH secretion; however, after several days, it desensitizes the receptors, leading to a profound decrease in the secretion of these hormones. As a result:
In men: Testosterone levels drop (chemical castration), controlling the progression of prostate cancer.
In women: Reduced estrogen levels improve endometriosis symptoms and shrink fibroids.
In children: Sex hormone levels fall, halting the process of precocious puberty. While initial effects are not instantaneous, regular monthly administration establishes stable disease control.
Store in the refrigerator at temperatures between 2°C to 8°C.
Protect from freezing.
Inspect the vial thoroughly for discoloration, particulate matter, or damage before use.
Verify the expiration date and dosage type.
Maintain sterile conditions during injection.
Rotate injection sites periodically to prevent inflammation.
The first injection must be performed under medical supervision. Reconstitution and deep intramuscular injection must strictly follow the provided instructions.
The use of Santorlin is prohibited or requires specialist consultation in the following cases:
Contraindications:
Hypersensitivity to Triptorelin or other GnRH analogues.
Pregnancy (strictly prohibited).
Severe liver disease.
Severe depression or a history of suicidal ideation.
Uncontrolled seizures.
Important Notes:
Women of childbearing age must use effective contraception methods.
Decisions regarding use during lactation must be made by a physician.
Do not discontinue the medication without medical advice.
Side effects are usually mild and tend to diminish as treatment continues:
Common Side Effects: Hot flashes, sweating, headache, fatigue, mood swings, restlessness, pain or reaction at the injection site, and decreased libido.
Potential Side Effects: Irregular menstruation in women (during the first few weeks), bone pain (especially in prostate patients), menopausal-like symptoms (dryness/warmth), and skin reactions at the injection site.
Contact a physician immediately if severe or unusual symptoms occur.
Santorlin is presented in a durable, standard box containing the lyophilized powder vial and a specialized solvent for injection. The components are placed in separate compartments to maintain sterility and product integrity. Detailed information including product name, dosage, batch number, expiration date, and storage conditions is clearly printed on the packaging. The design ensures safe and simple transportation, storage, and preparation.
1 review for Santorlin®
pars –
عالی